Home > Research Areas
Cat. No. Product name CAS No.
DC8336 Tizoxanide Featured

Tizoxanide is a potent inhibitor of hepatitis B virus and hepatitis C virus.

173903-47-4
DC8736 Tofacitinib Featured

Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent versus JAK2 and JAK1. Phase 3.

477600-75-2
DC5165 Tofacitinib (CP-690550) Citrate Featured

Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent versus JAK2 and JAK1. Phase 3.

540737-29-9
DC7826 Tofogliflozin hydrate

Tofogliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2).

1201913-82-7
DC8008 TOK-001(Galeterone) Featured

TOK-001 is a multifunctional antiandrogen and CYP17 inhibitor(IC50=47 nM) in castration resistant prostate cancer (CRPC).

851983-85-2
DC11485 Tolcapone Featured

Tolcapone is an orally active catechol-O-methyltransferase (COMT) inhibitor.

134308-13-7
DC9148 Tolvaptan Featured

Tolvaptan is a selective, competitive arginine vasopressin receptor 2 antagonist with an IC50 of 1.28μM for the inhibition of AVP-induced platelet aggregation.

150683-30-0
DC7519 Torcetrapib Featured

Torcetrapib is a CETP inhibitor with IC50 of 37 nM, elevates HDL-C and reduces nonHDL-C in plasma. Phase 3.

262352-17-0
DC9332 Tozadenant

Tozadenant (SYN-115) is an adenosine A2A receptor antagonist.

870070-55-6
DC8223 TP-0903 Featured

TP-0903 is a a high-affinity Axl inhibitor with IC50 of 27 nM.

1341200-45-0
DC10611 Trabectedin Featured

Trabectedin (Ecteinascidin-743 or ET-743) is a novel antitumour agent of marine origin with potent antitumour activity both in vitro and in vivo.

114899-77-3
DC1099 Trametinib Featured

Trametinib is a highly specific and potent MEK1 and MEK2 inhibitor with IC50 of 0.92 nM and 1.8 nM, respectively.

871700-17-3
DC6400 Tranilast (SB 252218) Featured

Tranilast (SB 252218)

53902-12-8
DC8824 Traxoprodil Featured

Traxoprodil is an NMDA ε 2 (NR2B) antagonist that has been studied as an alternative to serotonin selective reuptake inhibitors.

134234-12-1
DC7522 Triapine Featured

Triapine is a potent ribonucleotide reductase inhibitor with broad spectrum antitumor activity by inhibiting DNA synthesis. Phase 2.

143621-35-6
DC21567 Triazavirin (Riamilovir) Featured

Triazavirin is a guanine nucleotide analog antiviral originally developed in Russia that has shown efficacy against influenza A and B, including the H5N1 strain. It appears that Triazavirin has shown promise in reducing influenza disease severity and associated complications.5 Given the similarities between SARS-CoV-2 and H5N1, health officials are investigating Triazavirin as an option to combat SARS-CoV-2, the coronavirus responsible for COVID-19.

928659-17-0
DC9157 Trifluoperazine dihydrochloride

Trifluoperazine Dihydrochloride is a potent dopamine D2 receptor inhibitor used as an antipsychotic and an antiemetic.

440-17-5
DC12037 Triptolide Featured

Triptolide is the major bioactive constituent of T. wilfordii Hook F., also known as thunder god vine, a traditional Chinese medicinal herb with known antiproliferative, immunosuppressive, anti-inflammatory, antifertility, and anti-polycystic kidney disea

38748-32-2
DC9538 TRO 19622 Featured

TRO19622, a small cholesterol-like molecule, is a neuroregenerative and neuroprotective compound.

22033-87-0
DC11385 Trofinetide(NNZ2566) Featured

Trofinetide (NNZ-2566) is an analog of a molecule which is derived from IGF-1 and occurs naturally in the brain. IGF-1 is a growth factor stimulated by growth hormone.

853400-76-7
DC8903 Troglitazone

Troglitazone(CS-045), PPARγ agonist, is an anti-diabetic thiazolidinedione (TZD) with anti-inflammatory and anti-tumor activity.

97322-87-7
DC10737 Tropifexor (LJN452) Featured

Tropifexor (LJN452) is a highly potent non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH).

1383816-29-2
Page 53 / Total 59 FirstPrevNextLastGoto